Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 1952: Epigenetic modifiers outperform chemotherapy in prolonging survival in patient-derived xenograft models of Down syndrome AML

Cancer Res (2017) 77 (13_Supplement): 1952.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal